Ask Warren

Whanin Pharm

016580 · KOSPI · ₩016580 · 환인제약

₩10,230▲ ₩150 (1.49%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩71B₩71B₩65B₩66B₩64B₩60B₩66B₩68B
Cost of sales₩44B₩45B₩42B₩44B₩43B₩39B₩45B₩45B
Gross profit₩28B₩26B₩24B₩21B₩21B₩21B₩21B₩23B
Operating income₩7.9B₩9.4B₩1.5B₩3.6B₩2.7B₩5.3B₩913M₩5.3B
Net income₩233M₩7.5B₩10B₩88M−₩1.9B₩5.1B₩19B−₩1.7B
Net income to shareholders₩7.7B₩7.5B₩2B₩3.3B₩3.2B₩5.1B₩3.6B₩4.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩483B₩482B₩479B₩441B₩430B₩429B₩425B₩423B
Current assets₩240B₩232B₩228B₩218B₩205B₩207B₩201B₩199B
Cash and equivalents₩57B₩58B₩64B₩60B₩39B₩46B₩43B₩38B
Total liabilities₩57B₩58B₩58B₩47B₩49B₩53B₩49B₩49B
Current liabilities₩56B₩57B₩57B₩39B₩42B₩46B₩42B₩44B
Borrowings₩1.6B₩1.8B₩2B₩1.3B₩1.3B₩1.7B₩1.7B₩1.7B
Total equity₩425B₩424B₩421B₩394B₩380B₩376B₩376B₩374B
Shareholders' equity₩425B₩424B₩421B₩394B₩380B₩376B₩376B₩374B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩9.3B₩972M₩2.4B₩5.1B−₩2.3B₩3.9B₩3.6B₩9.5B
Free cash flow₩9.3B₩972M₩2.4B₩5.1B−₩2.3B₩3.9B₩3.6B₩9.5B
Dividends paid₩5.5B₩0₩0₩0₩4.6B₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: Whanin Pharm / 환인제약 / 016580 / KRX:016580

Source: KRX statistical information